Artificial intelligence (AI) models trained and validated in hospital-based populations to screen for structural heart disease are likely not to be effective in screening within the wider population due to differences in disease prevalence and phenotypes in the real world. This is according to a report from the PREVUE-VALVE study, a so-called “site-less” clinical trial […] The post Study highlights challenges in using AI-ECG detection to screen for structural heart disease appeared first on Cardiovascular News .